1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Dimerix Limited
  6. News
  7. Summary
    DXB   AU000000DXB7

DIMERIX LIMITED

(DXB)
Delayed Australian Stock Exchange  -  05/27 01:13:37 am EDT
0.1450 AUD    0.00%
05/08Dimerix Secures US FDA Approval for Phase 3 Kidney Trial; Shares Rise 4%
MT
05/08Dimerix Limited Announces Approval of Action3 Phase 3 Clinical Trial of DMX-200 in FSGS
CI
04/26DIMERIX : Quarterly Appendix 4C and Activities Report
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Dimerix : Notification regarding unquoted securities - DXB

12/05/2021 | 11:22pm EDT

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

For personal use only

Entity name

DIMERIX LIMITED

Date of this announcement

Monday December 06, 2021

The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

DXBAX

OPTION EXPIRING VARIOUS DATES EX

1,000,000

03/12/2021

VARIOUS PRICES

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

DIMERIX LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ABN

18001285230

1.3

ASX issuer code

DXB

  1. The announcement is New announcement
  2. Date of this announcement

6/12/2021

Notification of Issue, Conversion or Payment up of Unquoted

2 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

For personal use only

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

has an existing ASX security code ("existing class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B

only

ASX +security code and description

DXBAX : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Date the +securities the subject of this notification were issued

3/12/2021

use

Will these +securities rank equally in all respects from their issue date with the existing issued

+securities in that class

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

No

personalFor

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme

or a summary of the terms

https://www.asx.com.au/asxpdf/20191029/pdf/449zmqvrl86lkb.pdf

Any other information the entity wishes to provide about the +securities the subject of this notification

1,000,000 Unlisted Options exercisable at $0.40 and expiring on 03 December 2025 pursuant to ESOP.

I ue details

Number of +securities 1,000,000

Notification of Issue, Conversion or Payment up of Unquoted

4 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 4 - +Securities on issue

For personal use only

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +Securities (Total number of each +class of +securities quoted)

Total number of

ASX +security code and description

+securities on issue

DXB : ORDINARY FULLY PAID

320,873,666

4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)

Total number of

ASX +security code and description

+securities on issue

DXBAX : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

77,951,112

Notification of Issue, Conversion or Payment up of Unquoted

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Dimerix Ltd. published this content on 06 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 December 2021 04:21:02 UTC.


© Publicnow 2021
All news about DIMERIX LIMITED
05/08Dimerix Secures US FDA Approval for Phase 3 Kidney Trial; Shares Rise 4%
MT
05/08Dimerix Limited Announces Approval of Action3 Phase 3 Clinical Trial of DMX-200 in FSGS
CI
04/26DIMERIX : Quarterly Appendix 4C and Activities Report
PU
03/28Dimerix Receives $3 Million Tax Rebate; Shares Rise 3%
MT
02/28DIMERIX : Investor Call and Presentation
PU
02/27Dimerix Limited Announces DSMB Change to REMAP-CAP COVID-19 Study
CI
02/23DIMERIX : Half-Year Financial Report & Appendix 4D - 31 December 2021
PU
02/23Dimerix Limited Reports Earnings Results for the Half Year Ended December 31, 2021
CI
02/06Dimerix Names New Chief Medical Officer
MT
02/06Dimerix Limited Appoints Dr. Ash Soman as Chief Medical Officer
CI
More news
Financials
Sales 2021 4,44 M 3,18 M 3,18 M
Net income 2021 -6,37 M -4,56 M -4,56 M
Net cash 2021 0,16 M 0,11 M 0,11 M
P/E ratio 2021 -6,06x
Yield 2021 -
Capitalization 46,5 M 33,3 M 33,3 M
EV / Sales 2020 26,7x
EV / Sales 2021 8,66x
Nbr of Employees -
Free-Float 73,5%
Chart DIMERIX LIMITED
Duration : Period :
Dimerix Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIMERIX LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Nina Webster Chief Executive Officer, MD & Director
Hamish George Chief Financial Officer & Secretary
James Howard Williams Non-Executive Chairman
David Packham Chief Medical Officer
Robert Shepherd Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
DIMERIX LIMITED-40.82%33
MODERNA, INC.-46.53%54 016
LONZA GROUP AG-28.07%42 292
IQVIA HOLDINGS INC.-26.37%39 319
SEAGEN INC.-10.44%25 487
ICON PUBLIC LIMITED COMPANY-29.73%17 693